BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin Z, Ye W, Lan T, Zhao Y, Liu X, Chen J, Lai J, Chen S, Zhong X, Wu X. Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ γδ T Cells in AML Patients. Biomed Res Int 2020;2020:4612952. [PMID: 32802845 DOI: 10.1155/2020/4612952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shao R, Wang H, Wang J, Lu S, He R, Lu Y. Comprehensive analysis of a pyroptosis-related gene signature of clinical and biological value in acute myeloid leukaemia. International Immunopharmacology 2022;108:108802. [DOI: 10.1016/j.intimp.2022.108802] [Reference Citation Analysis]
2 Annese T, Tamma R, Ribatti D. Update in TIGIT Immune-Checkpoint Role in Cancer. Front Oncol 2022;12:871085. [PMID: 35656508 DOI: 10.3389/fonc.2022.871085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang D, Gu Y, Yan X, Huo C, Wang G, Zhao Y, Teng M, Li Y. Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy. Front Oncol 2022;12:844260. [PMID: 35433470 DOI: 10.3389/fonc.2022.844260] [Reference Citation Analysis]
4 Qiu D, Liu X, Wang W, Jiang X, Wu X, Zheng J, Zhou K, Kong X, Wu X, Jin Z. TIGIT axis: novel immune checkpoints in anti-leukemia immunity. Clin Exp Med 2022. [PMID: 35419661 DOI: 10.1007/s10238-022-00817-0] [Reference Citation Analysis]
5 Kong X, Zheng J, Liu X, Wang W, Jiang X, Chen J, Lai J, Jin Z, Wu X. High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia. Front Immunol 2022;13:823352. [PMID: 35222403 DOI: 10.3389/fimmu.2022.823352] [Reference Citation Analysis]
6 Brauneck F, Weimer P, Schulze Zur Wiesch J, Weisel K, Leypoldt L, Vohwinkel G, Fritzsche B, Bokemeyer C, Wellbrock J, Fiedler W. Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma. Front Med (Lausanne) 2021;8:763773. [PMID: 34820398 DOI: 10.3389/fmed.2021.763773] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Shao R, Wang H, Liu W, Wang J, Lu S, Tang H, Lu Y. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia. J Cell Mol Med 2021;25:10950-60. [PMID: 34741393 DOI: 10.1111/jcmm.17013] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Barros MS, de Araújo ND, Magalhães-Gama F, Pereira Ribeiro TL, Alves Hanna FS, Tarragô AM, Malheiro A, Costa AG. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends. Front Immunol 2021;12:729085. [PMID: 34630403 DOI: 10.3389/fimmu.2021.729085] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Ye W, Kong X, Zhang W, Weng Z, Wu X. The Roles of γδ T Cells in Hematopoietic Stem Cell Transplantation. Cell Transplant 2020;29:963689720966980. [PMID: 33073597 DOI: 10.1177/0963689720966980] [Reference Citation Analysis]